menu
    • menu

    Company profile for Paratek Pharmaceuticals

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Paratek, solutions are provided that enable positive outcomes and lead to positive patient stories. Paratek Pharmaceuticals is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments.We focus on drugs that target infectious disease and other difficult to treat conditions.Today, we have a particularly promisi...
    At Paratek, solutions are provided that enable positive outcomes and lead to positive patient stories. Paratek Pharmaceuticals is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments.We focus on drugs that target infectious disease and other difficult to treat conditions.Today, we have a particularly promising antibiotic called Omadacycline for serious community acquired infections where resistance is of concern.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Paratek PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    75 Park Plaza 4th Floor Boston, MA 02116
    Telephone
    Telephone
    617-807-6600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.paratekpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/paratek-pharmaceuticals-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Paratek Pharmaceuticals Completes Combination with Radius Health
    Paratek Pharmaceuticals Completes Combination with Radius Health

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258017/0/en/Paratek-Pharmaceuticals-Completes-Combination-with-Radius-Health-Expanding-Its-Multi-Product-Specialty-Commercial-Platform.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Paratek Pharma To Unveil NUZYRA® Data At Idweek & CHEST 2025
    Paratek Pharma To Unveil NUZYRA® Data At Idweek & CHEST 2025

    17 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/17/3168554/0/en/Paratek-Pharmaceuticals-to-Present-New-Data-on-NUZYRA-omadacycline-at-IDWeek-2025-and-CHEST-2025.html

    GLOBENEWSWIRE
    17 Oct 2025
    Share Share
    Paratek Pharmaceuticals Acquires Optinose, Expanding Portfolio
    Paratek Pharmaceuticals Acquires Optinose, Expanding Portfolio

    21 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/21/3085707/0/en/Paratek-Pharmaceuticals-Completes-Acquisition-of-Optinose-Creating-an-Expanded-Portfolio-of-Specialty-Therapies.html

    GLOBENEWSWIRE
    21 May 2025
    Share Share
    Paratek Pharmaceuticals to Present NUZYRA Data at ATS 2025
    Paratek Pharmaceuticals to Present NUZYRA Data at ATS 2025

    16 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/16/3083010/0/en/Paratek-Pharmaceuticals-to-Present-Clinical-Data-on-NUZYRA-omadacycline-at-the-American-Thoracic-Society-ATS-2025-International-Conference.html

    GLOBENEWSWIRE
    16 May 2025
    Share Share
    Paratek Pharmaceuticals to Present Nuzyra Data at ESCMID Global
    Paratek Pharmaceuticals to Present Nuzyra Data at ESCMID Global

    10 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/10/3059143/0/en/Paratek-Pharmaceuticals-to-Present-New-Data-on-NUZYRA-omadacycline-at-ESCMID-Global-2025.html

    GLOBENEWSWIRE
    10 Apr 2025
    Share Share
    Paratek buys Optinose, rhinosinusitis spray Xhance for up to $330M
    Paratek buys Optinose, rhinosinusitis spray Xhance for up to $330M

    21 Mar 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/paratek-acquires-optinose-and-rhinosinusitis-spray-xhance-330m

    FIERCE PHARMA
    21 Mar 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search